https://www.selleckchem.com/pr....oducts/Raltitrexed.h
5 score increase a step-wise augmentation of BARC 3 or 5 bleeding rates at 1 year ranging from 1.90% among patients fulfilling no criterion, through 4.01%, 5.98%, 7.42%, 8.60%, 12.21%, 12.29%, and 17.64%. All major and five out of six minor criteria, conferred in isolation a risk for BARC 3 or 5 bleeding at 1 year exceeding 4% at the upper limit of the 95% confidence intervals. All major and the majority of minor ARC-HBR criteria identify in isolation patients at HBR. All major and the majority of minor ARC-HBR criteria identify in
Like
Comment
Share
